0000-00-00 |
|
|
|
External link to document |
2022-12-16 |
111 |
Notice of Service |
Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495; and…Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033, 8,809,322, 9,289,432, and 9,687,495 filed… 26 August 2021
1:21-cv-01229
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2023-02-15 |
117 |
Notice of Service |
Hugh Smyth Regarding the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322 filed by Hananja EHF, UCB … 26 August 2021
1:21-cv-01229
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2023-03-15 |
119 |
Notice of Service |
Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322; and (2) Reply Expert Report…Non-Obviousness Supporting the Validity of U.S. Patent Nos. 8,217,033 and 8,809,322 filed by Hananja EHF, UCB … 26 August 2021
1:21-cv-01229
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-08-26 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,217,033 B2 ;8,809,322 B2 ;9,289,432… 26 August 2021
1:21-cv-01229
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |